Scale Up

Architect's illustration showing Algae Biosciences' production facilities near Holbrook, Ariz., at completion of its $5-million first phase of expansion.

Architect's illustration showing Algae Biosciences' production facilities near Holbrook, Ariz., at completion of its $5-million first phase of expansion.

AlgaeBio Prepares for Omega-3 Launch

July 4, 2012

Algae BioSciences, an Arizona-based biotechnology company now completing a $5-million, first-phase expansion process, will soon begin commercial production of its ultra-pure omega-3 fatty acid oils. The oils will be sourced from marine algae and grown in Arizona sunlight, at the company’s production facilities in the high desert plains near Holbrook.

The initial output of AlgaeBio’s algal oils – which will be packaged for consumers by Global Health Trax (GHT) as AlgaeBio Omega-3 Origins™, and made available in both adult and child dosages – will contain long-chain essential fatty acids EPA (eicosapentaenoic acid) and DHA.

Because these marine algae are cultured through photosynthesis, AlgaeBio Omega-3 Origins™ will also include beneficial compounds such as phytosterols, chlorophyll, Vitamins C, D, and E, and the carotenoids beta-carotene, lutein, fucoxanthin, and zeaxanthin. And because they are algae-based, the oils will contain higher ORAC (oxygen radical absorbance capacity) values, gram for gram, than nearly any land-based foods.

AlgaeBio and GHT, of Vista, Calif., have in place a sales and distribution contract that gives GHT exclusive rights to purchase and distribute AlgaeBio’s oils to the nutraceutical, food additive, and animal feed markets.

AlgaeBio Product-lines

Thanks to some recent scientific research, the public can now be certain that these vegetarian-based polyunsaturated fatty acids (PUFAs) are as effective as fish-based omega-3s in providing health benefits.

Researchers involved in three independent studies focusing on pregnancy and infancy, all of them using algae-sourced docosahexaenoic acid (DHA), reported beneficial results when they presented their findings late last month at the 10th Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL) in Vancouver.

In one study, led by Dr. Susan E. Carlson of the University of Kansas Medical Center, it was found that prenatal algal DHA supplementation – 600 mg daily, from 14 weeks gestation through delivery – increased DHA blood levels in both mother and infant, as well as newborn birth weight, length, and head circumference.

A second study – the DHA Intake and Measurement of Neural Development (DIAMOND) study, led by Dr. John Colombo – concluded that supplementation with DHA and arachidonic acid (ARA), an omega-6 fatty acid, from the ages of 18 months to six years provides cognitive and developmental benefits evident through the age of six. Meanwhile, Drs. Kelly Mulder and Sheila Innis, of the University of British Columbia, presented their own study that found prenatal DHA deficiency may well limit development potential among infants.

These three studies are particularly significant because they represent some of the first research to concentrate specifically on the health benefits of algal omega-3s, according to AlgaeBio’s Vice-President of Corporate Development and Marketing, Dr. Mark Edwards.

“When we do GRAS (Generally Recognized As Safe) analysis, we want to be able to say our processes yield something similar to what’s already known,” says Dr. Edwards, who is also an Arizona State University professor, award-winning author, and renowned “algaevangelist” focusing on algae’s potential in freedom foods, agribusiness, and sustainable energy.

“The question we have here is: are omega-3s omega-3s? Are fish-based omega-3s equal to algae-based omega-3s? Logically, of course, there shouldn’t be any question, because fish get their omega-3 oils from algae,” adds Dr. Edwards. “What these studies do is demonstrate what we thought all along, but didn’t know for sure – that algae-based omega-3s have therapeutic effects similar to those in fish oil.”

More Like This…

HOME Algae Industry Jobs

Copyright ©2010-2012 All rights reserved. Permission granted to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
Portuguese cement facility, Secil, and microalgae biotechnology company, A4F, also based in Portugal, have formed AlgaFarm, a joint venture to develop the use of cement f...
With their new CO₂ processing-platform called AstaCos, AlgaeBiotech can produce waxy particles of only 50-100 µm in size with a loading of 25% astaxanthin oleoresin. The ...
Cyanobacteria, also known as blue-green algae because of their color, have endured for more than 2.5 billion years, providing ample time to adapt to changes in the Earth'...
Allan Koay writes in about a Universiti Malaya research project paving the way for the commercial production of paper pulp and bioethanol from seaweed. The Al...
Much of the development of the algae industry in 2014 was driven by domestic and international alliances, partnerships, and mergers that brought complementary skills and ...
Green Star Products, Inc. (GSPI) has signed a contract to build a demonstration facility in Las Vegas, Nevada, to produce commercial quality algae. The Hybrid Algae Produ...